CN117379517A - 一种跌打损伤药酒 - Google Patents
一种跌打损伤药酒 Download PDFInfo
- Publication number
- CN117379517A CN117379517A CN202311312082.9A CN202311312082A CN117379517A CN 117379517 A CN117379517 A CN 117379517A CN 202311312082 A CN202311312082 A CN 202311312082A CN 117379517 A CN117379517 A CN 117379517A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicinal liquor
- traumatic injury
- raw materials
- liquor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014674 injury Diseases 0.000 title claims abstract description 18
- 230000008736 traumatic injury Effects 0.000 title claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 13
- 239000011521 glass Substances 0.000 claims abstract description 11
- 238000004140 cleaning Methods 0.000 claims abstract description 6
- 238000001035 drying Methods 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract 2
- 238000010298 pulverizing process Methods 0.000 claims abstract 2
- 241000931143 Gleditsia sinensis Species 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 12
- 241000270708 Testudinidae Species 0.000 claims description 11
- 239000010985 leather Substances 0.000 claims description 11
- 241000432824 Asparagus densiflorus Species 0.000 claims description 8
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 6
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 5
- 235000020097 white wine Nutrition 0.000 claims description 5
- 235000014375 Curcuma Nutrition 0.000 claims description 4
- 244000164480 Curcuma aromatica Species 0.000 claims description 4
- 240000009138 Curcuma zedoaria Species 0.000 claims description 4
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims description 4
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 4
- 235000019509 white turmeric Nutrition 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 240000007926 Ocimum gratissimum Species 0.000 claims 2
- 235000014101 wine Nutrition 0.000 claims 2
- 244000003416 Asparagus officinalis Species 0.000 claims 1
- 235000010837 Echinocereus enneacanthus subsp brevispinus Nutrition 0.000 claims 1
- 235000006850 Echinocereus enneacanthus var dubius Nutrition 0.000 claims 1
- 244000157072 Hylocereus undatus Species 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 210000002435 tendon Anatomy 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract description 3
- 208000025978 Athletic injury Diseases 0.000 abstract description 2
- 206010041738 Sports injury Diseases 0.000 abstract description 2
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 206010064470 Muscle swelling Diseases 0.000 abstract 1
- 208000000112 Myalgia Diseases 0.000 abstract 1
- 208000013465 muscle pain Diseases 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000234427 Asparagus Species 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 241001529734 Ocimum Species 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种跌打损伤药酒，涉及中医药技术领域，能够舒筋活络，行气活血，消除疲劳。所述用于舒筋活络的药酒，药效的主要成分由以下原料制备而成：石龟板、莪术、皮子王、三棱、大罗伞、小罗伞、皂角、白芷、了刁竹、白酒，将原料全部洗净，自然干燥后全部粉碎成粉末状颗粒并混匀，再将混匀的原料加入到盛有白酒的玻璃瓶中，浸泡数日，过滤即得。所述药酒能够治疗运动损伤，能快速缓解肌肉肿痛。
Description
技术领域
本发明涉及药酒技术领域，更具体地说，它涉及一种跌打损伤药酒。
背景技术
在日常生活以及体育运动中，大多数人都会因各种各样的意外事件，导致肌肉损伤，以肿胀、疼痛为主要表现。直接因撞、跌倒等引起的损伤，如不及时快速有效的治疗处理，有可能留下健康隐患，降低生活品质。对于劳动者，长期体力劳动会对肩颈部的肌肉造成劳损，长期不加以治疗，使得病情进一步加重，最后会影响日常生活。
发明内容
本发明要解决的技术问题是针对上述的不足，本发明的目的一是提供一种跌打损伤药酒。
本发明的目的二是提供一种跌打损伤药酒的制备方法。
为了实现上述目的，本发明提供一种跌打损伤药酒，药效的成分由以下原料制备而成：石龟板、莪术、皮子王、三棱、大罗伞、小罗伞、皂角、白芷、了刁竹、白酒。
各原料的重量组分为:20～30份石龟板、15～30份莪术、20～35份皮子王、20～40份三棱、15～30份大罗伞、15～35份小罗伞、20～40份皂角、35～50份白芷、25～40份了刁竹、1000份度数为65°的白酒。
各原料的重量组分为25份石龟板、20份莪术、25份皮子王、30份三棱、25份大罗伞、20份小罗伞、30份皂角、40份白芷、30份了刁竹、1000份白酒。
制备步骤：
(1)先将石龟板、莪术、皮子王、三棱、大罗伞、小罗伞、皂角、白芷、了刁竹全部洗净，自然干燥后备用；
(2)将白酒装入能密封的玻璃瓶中；
(3)将步骤(1)中备用的原料全部粉碎成细度为100目的粉末状颗粒并混匀；
(4)将步骤(3)中混匀的原料加入到盛有白酒的玻璃瓶中；
(5)浸泡时间为25～35日；
(6)用纱布过滤，得到的液体即为药酒。
本发明使用的药材的作用:
石龟板:石龟板是龟的腹甲，又名龟甲。龟板的主体成份为动物胶、角质、蛋白质、脂肪、磷和钙盐等，并含无机物(碳酸钙、磷酸钙)，蛋白质，其他成份，其具有的药用疗效：滋阴壮阳、益肾健骨、凉血止血。常用于阴虚火旺，筋骨不健。
莪术:又名蓬药，味辛、苦，性温。归肝、脾经。具有行气破血，消积止痛之功效。常用于血气心痛，饮食积滞，脘腹胀痛，血滞经闭，痛经，癓瘕痞块，跌打损伤。
皮子王:又名篦子王，味微苦，性平。归肝、肾经。具有祛风湿、活血止痛、壮筋骨、强筋骨、祛瘀止痛、补肾强腰的功效。常用于跌打损伤、痛经。
三棱:味辛、苦，性平。归肝、脾经。具有破血行气，消积止痛的功效。用于症瘕痞块，痛经，瘀血经闭，胸痹心痛，食积胀痛。
大罗伞:味苦，性凉。归肺、肝经。具有清热降火、消肿解毒、活血去瘀、祛痰止咳等功效。用于治疗咽喉肿痛，风湿痹痛，跌打损伤等症。
小罗伞:味苦甘辛，性温。归肝、膀胱、肾经。具有活血调经，祛风除湿的功效。常用于经闭，痛经，风湿痹痛，跌打损伤。
皂角:味辛、咸，性温。归肺、大肠经。具有开窍祛痰、散结消肿、润燥通便，属涌吐药的功效。常用于关窍不通、喉痹痰阻。
白芷:味辛，性温。归肺、脾、胃经。具有解表散寒，祛风止痛，通鼻窍，燥湿止带，消肿排脓，祛风止痒的功效。主治风寒感冒，头痛、牙痛、风湿痹痛，鼻渊，带下证，疮痈肿毒。
了刁竹:味辛，性温。归肝、胃经，具有镇痛，止咳，利水消肿，活血解毒的功效。主治胃痛，牙痛，风湿疼痛，经期腹痛，慢性气管炎，腹水，水肿，痢疾，肠炎，跌打损伤，湿疹，荨麻疹，毒蛇咬伤。
有益效果
本发明具有的优点为：
本发明的药酒制备过程简单易行，容易实现，且具有舒筋活络，行气活血，消除疲劳的积极效果，对腰酸背痛、跌打损伤、运动受损导致的肌肉酸痛都有明显的疗效。
具体实施方式
下面结合中的具体实施例对本发明做进一步的说明。
一种跌打损伤药酒，药效的成分由以下原料制备而成：石龟板、莪术、皮子王、三棱、大罗伞、小罗伞、皂角、白芷、了刁竹、白酒。
各原料的重量组分为:20～30份石龟板、15～30份莪术、20～35份皮子王、20～40份三棱、15～30份大罗伞、15～35份小罗伞、20～40份皂角、35～50份白芷、25～40份了刁竹、1000份度数为65°的白酒。
实施例一：
各原料的重量组分为25份石龟板、20份莪术、25份皮子王、30份三棱、25份大罗伞、20份小罗伞、30份皂角、40份白芷、30份了刁竹、1000份白酒。
包括以下制备步骤：
(1)先将石龟板、莪术、皮子王、三棱、大罗伞、小罗伞、皂角、白芷、了刁竹全部洗净，自然干燥后备用；
(2)将白酒装入能密封的玻璃瓶中；
(3)将步骤(1)中备用的原料全部粉碎成粉末状颗粒并混匀，粉末状颗粒细度为100目；
(4)将步骤(3)中混匀的原料加入到盛有白酒的玻璃瓶中；
(5)浸泡时间为30日；
(6)用纱布过滤，得到的棕色滤液即为药酒。
实施例二：
各原料的重量组分为20份石龟板、15份莪术、20份皮子王、20份三棱、15份大罗伞、20份小罗伞、30份皂角、40份白芷、35份了刁竹、1000份白酒。
包括以下制备步骤：
(1)先将石龟板、莪术、皮子王、三棱、大罗伞、小罗伞、皂角、白芷、了刁竹全部洗净，自然干燥后备用；
(2)将白酒装入能密封的玻璃瓶中；
(3)将步骤(1)中备用的原料全部粉碎成粉末状颗粒并混匀，粉末状颗粒细度为100目；
(4)将步骤(3)中混匀的原料加入到盛有白酒的玻璃瓶中；
(5)浸泡时间为25日；
(6)用纱布过滤，得到的棕色滤液即为药酒。
实施例三：
各原料的重量组分为:30份石龟板、30份莪术、30份皮子王、40份三棱、25份大罗伞、30份小罗伞、15份皂角、40份白芷、30份了刁竹、1000份白酒。
包括以下制备步骤：
(1)先将石龟板、莪术、皮子王、三棱、大罗伞、小罗伞、皂角、白芷、了刁竹全部洗净，自然干燥后备用；
(2)将白酒装入能密封的玻璃瓶中；
(3)将步骤(1)中备用的原料全部粉碎成粉末状颗粒并混匀，粉末状颗粒细度为100目；
(4)将步骤(3)中混匀的原料加入到盛有白酒的玻璃瓶中；
(5)浸泡时间为35日；
(6)用纱布过滤，得到的棕色滤液即为药酒。
典型病例：
病例1：张某，男，27岁，运动后肌肉损伤且伴随肿痛，在行走时疼痛加剧，行动不便。使用本发明的药酒，将药液喷于患处轻柔，再将浸有药液的药棉敷在患处20分钟，每日3次，一周后，肿痛消失，患者痊愈。
病例2：陈某某，男，35岁，因过度劳累肩颈部酸痛，活动受限，尤其在天气转冷时症状加重。使用本发明的药酒，将药液喷于患处轻柔10-20分钟，每日3次，一星期后症状明显改善，天气变化时无明显症状。
病例3：李某，女，31岁，因运动时碰撞造成腿部肿痛，使得腿部活动受限。使用本发明的药酒，将药液喷于患处轻柔10-20分钟，每日3次，5天后患者痊愈，无不适症状。
病例4：王某，男，38岁，长期从事体力劳动，使得背部肌肉劳损，夜间睡觉时疼痛，入眠困难。使用本发明的药酒，将浸有药酒的药棉敷在背部，每日3次，每次20分钟，使用半个月后症状减轻，坚持使用一个月后，症状明显改善。
以上仅是本发明的优选实施方式，应当指出对于本领域的技术人员来说，在不脱离本发明结构的前提下，还可以作出若干变形和改进，这些都不会影响本发明实施的效果和专利的实用性。
Claims (6)
1.一种跌打损伤药酒，其特征在于，药效的成分由以下原料制备而成：石龟板、莪术、皮子王、三棱、大罗伞、小罗伞、皂角、白芷、了刁竹、白酒。
2.根据权利要求1所述的一种跌打损伤药酒，其特征在于，各原料的重量组分为:20～30份石龟板、15～30份莪术、20～35份皮子王、20～40份三棱、15～30份大罗伞、15～35份小罗伞、20～40份皂角、35～50份白芷、25～40份了刁竹、1000份白酒。
3.根据权利要求1所述的一种跌打损伤药酒，其特征在于，所述白酒度数为65°。
4.根据权利要求2所述的一种跌打损伤药酒，其特征在于，所述各原料的重量组分为25份石龟板、20份莪术、25份皮子王、30份三棱、25份大罗伞、20份小罗伞、30份皂角、40份白芷、30份了刁竹、1000份白酒。
5.根据权利要求1所述的一种跌打损伤药酒，其特征在于，包括制备步骤：
(1)先将石龟板、莪术、皮子王、三棱、大罗伞、小罗伞、皂角、白芷、了刁竹全部洗净，自然干燥后备用；
(2)将白酒装入能密封的玻璃瓶中；
(3)将步骤(1)中备用的原料全部粉碎成粉末状颗粒并混匀；
(4)将步骤(3)中混匀的原料加入到盛有白酒的玻璃瓶中；
(5)浸泡时间为25～35日；
(6)用纱布过滤，得到的液体即为药酒。
6.根据权利要求5所述的一种跌打损伤药酒，其特征在于，所述粉末状颗粒细度为100目。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311312082.9A CN117379517A (zh) | 2023-10-11 | 2023-10-11 | 一种跌打损伤药酒 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311312082.9A CN117379517A (zh) | 2023-10-11 | 2023-10-11 | 一种跌打损伤药酒 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117379517A true CN117379517A (zh) | 2024-01-12 |
Family
ID=89435357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311312082.9A Pending CN117379517A (zh) | 2023-10-11 | 2023-10-11 | 一种跌打损伤药酒 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117379517A (zh) |
-
2023
- 2023-10-11 CN CN202311312082.9A patent/CN117379517A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101543610B (zh) | 一种有效治疗痛经的药酒 | |
| CN104107338A (zh) | 一种治疗风湿病的药酒 | |
| CN103550641A (zh) | 用于治疗慢性肾盂肾炎的组方肾精丸及制备方法 | |
| CN102430068B (zh) | 一种醋与中药结合化瘀健肾治关节痛热敷醋及其配制方法 | |
| CN107007724B (zh) | 一种中药保健液及其制备方法 | |
| CN107095905A (zh) | 一种保健灸条及灸膏 | |
| CN103083616B (zh) | 一种治疗卵巢囊肿的中药 | |
| CN110115751A (zh) | 一种治疗内外伤病痛的全息循经修复止痛外用药酒及其制备方法 | |
| CN104721614A (zh) | 一种用于治疗关节脱位的中药制剂及制备方法 | |
| CN117379517A (zh) | 一种跌打损伤药酒 | |
| CN109381627B (zh) | 一种治疗尿毒症的药物及其制备方法 | |
| CN105878627A (zh) | 一种治疗近视眼病的中药配方 | |
| CN113476577A (zh) | 一种治疗风湿痹痛及跌打损伤的中药组合物及其制备方法 | |
| CN101766740B (zh) | 一种用于消除疤痕的中药组合物及其制备方法 | |
| CN108837030A (zh) | 一种治疗骨质增生的中药组合物及其制备方法和应用 | |
| CN108245564B (zh) | 一种黑膏药及其制备方法 | |
| CN108721579A (zh) | 缓解颈肩疼痛的中药组合物 | |
| CN106072399A (zh) | 一种香辣椒的制作工艺 | |
| CN106728955A (zh) | 一种治疗肢体疼痛、麻木的热敷药 | |
| CN106214870A (zh) | 一种治疗风湿关节炎的足浴粉及其制备方法 | |
| CN106434207A (zh) | 一种天麻保健酒 | |
| CN114209788A (zh) | 一种治疗八种疑难病的药物及其制备方法 | |
| CN114452361A (zh) | 一种治疗颈肩腰腿痛的外敷膏药及其制备方法 | |
| CN104288623B (zh) | 一种治疗腰间盘突出的药酒 | |
| CN109908285A (zh) | 一种调理男性生殖健康的中药组合物及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |